8-K

Company

Akari Therapeutics Plc

Filed

November 25, 2015

Period of Report

November 19, 2015

Accession Number

0001144204-15-068083

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →